Most Expensive Drugs 2025: Trends and Implicati...

By João L. Carapinha

August 13, 2025

What are the most expensive drugs 2025, and how do they shape patient access, healthcare spending, and industry innovation in the US? As 2026 approaches, the most expensive drugs 2025 are led by advanced gene therapies and rare disease biologics, ...
Global Health Technology Assessment: Navigating NICE’s Role and Challen...
Model Type and Its Impact on Pneumococcal Vaccine Cost-Effectiveness in Germany
National Bulk Purchasing Strategy: Enhancing Drug Affordability and Access in...
Lenacapavir HIV Prevention: Gilead’s Strategic Agreement to Enhance Acc...
Talquetamab Multiple Myeloma: Impact, Evidence, and Policy Considerations
Impending Net Drug Price Transparency Regulation in the U.S.
Pharmaceutical Pricing Issues: Beyond Overpricing and Profit Motives
NICE Rejects Donanemab: Treatment Cost-Effectiveness
Pfizer Conference Insights: Analyzing Bourla’s Strategic Vision Amid Po...
Revitalizing Innovation: The Impact of UK Medicine Payment Rates
Enhertu Reimbursement Analysis: Navigating Cost-Effectiveness Challenges
NICE’s Approval of Marstacimab for Hemophilia B: Transforming Treatment...